[1]宋巧云,孙春秀,赵霞,等.D-二聚体、P选择素及超敏C反应蛋白联合检测在2型糖尿病肾病中的诊断价值[J].中国医学装备,2013,10 ( 5):80- 83. [2]赵文杰,周洪兴,曹琦,等.血浆 D-二聚体与内毒素水平对判断非小细胞肺癌患者预后的意义[J].临床检验杂志,2012,30 ( 5):340- 342. [3]Yang Q, Xie RJ, Yang T. Transforming growth factor-beta1 and Smad4 signaling pathway down-regulates renal extracellular matrix degradation in diabetic rats.Chin Med Sci J, 2007, 22(4): 243-249. [4]Fouque D, AparicioM. Eleven reasons to control the proten intake of patients with chronic kidney disease. Nat. Clin Pratt Nephrol, 2007, 7(3): 383-392. [5]郑兴忠.联合检查D-二聚体、纤维蛋白原和C反映蛋白在2型糖尿病肾病中临床应用价值[J].浙江临床医学,2011,13 ( 3):244- 248. [6]舒囧,王曼曼,陈宣容, 等.2型糖尿病肾病患者sGFR及其冠状动脉320-DVCT相关性分析[J].中山大学学报(医学科学版), 2013,34 (2):271- 275. [7]罗兵,杨胜利.阿魏酸钠联合氯沙坦治疗2型糖尿病肾病临床疗效观察[J].河北医学,2013,19 (6):899-901. [8]景永宏,聂晓莲,邢小利,等.血清胱抑素C检测对2型糖尿病肾病诊断的影响研究[J].河北医药,2012,34 ( 22):3413- 3415. [9]王照峰,张虎,赵瑞敏,等.D-二聚体、FIB检测在2型糖尿病合并微血管病变时的临床意义[J].空军医学杂志,2012,28 ( 3):132- 133. [10] Wang T,Wang Q,Wang Z,et al.Diagnostic value of the com-bined measurement of serum hcy,serum Cys C,and urinary mi-croalbumin in Type 2 diabetes mellitus with early complicating diabetic nephropathy[J].ISRN Endocrinology,2013. [11] 李春北,张燕燕. 胱抑素C与超敏C反应蛋白对2型糖尿病早期肾损害的诊断意义[J]. 检验医学与临床,2011,32(4):639-640. [12].Hosokawa Y,Yamada Y,Obata Y,et al. Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients[J].Clin Exp Nephrol, 2012,16( 3): 399- 405. [13] 朱槿宏,元淑巧,于海涛等. 胱抑素C在肾功能评价中的临床意义[J]. 中国卫生检验杂志,2011,21(6):1569-1570. [14] Jiao B,Zhang YH,Cheng YN,et al. A low-dose combination of valsartan and low molecular weight heparin better improved glomerular permeability than did high-dose monotherapy in rats with diabetic nephropathy[J].Drug Discoveries & Therapeutics,2011,5( 3) :119.
|